Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)
Bonora, S, Rusconi, S, Calcagno, A, Bracchi, M, Viganò, O, Cusato, J, Lanzafame, M, Trentalange, A, Marinaro, L, Siccardi, M, D'Avolio, A, Galli, M, Di Perri, G
Published in Journal of antimicrobial chemotherapy (01.11.2015)
Published in Journal of antimicrobial chemotherapy (01.11.2015)
Get full text
Journal Article
Analysis of determinants of long‐term efficacy of unboosted atazanavir‐based regimens in the clinical setting
Bonora, S, Calcagno, A, Viganò, O, Bigliano, P, Rusconi, S, Trentini, L, Tettoni, MC, Orofino, G, Salassa, B, Bramato, C, D'Avolio, A, Siccardi, M, Colella, E, Galli, M, Di Perri, G
Published in Journal of the International AIDS Society (01.11.2010)
Published in Journal of the International AIDS Society (01.11.2010)
Get full text
Journal Article
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients
Bonora, S, Calcagno, A, Vigano, O, Bigliano, P, Marinaro, L, Colella, E, Orofino, G, Trentini, L, Tettoni, M C, D'Avolio, A, Mercadante, S, Galli, M, Di Perri, G, Rusconi, S
Published in Current HIV research (01.01.2014)
Published in Current HIV research (01.01.2014)
Get more information
Journal Article
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A128 polymorphism carriers
Ferraris, Laurenzia, Viganò, Ottavia, Peri, Anna, Tarkowski, Maciej, Milani, Greta, Bonora, Stefano, Adorni, Fulvio, Gervasoni, Cristina, Clementi, Emilio, Di Perri, Giovanni, Galli, Massimo, Riva, Agostino
Published in Journal of antimicrobial chemotherapy (01.09.2012)
Published in Journal of antimicrobial chemotherapy (01.09.2012)
Get full text
Journal Article
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens
GONZALEZ DE REQUENA, Daniel, BONORA, Stefano, VITIELLO, Paola, GALLI, Massimo, RUSCONI, Stefano, DI PERRI, Giovanni, VIGANO, Ottavia, CALCAGNO, Andrea, COMETTO, Cristina, D'AVOLIO, Antonio, BAIETTO, Lorena, GHISETTI, Valeria, MAGNANI, Silvia, FERRAMOSCA, Stefania
Published in Journal of antimicrobial chemotherapy (2011)
Published in Journal of antimicrobial chemotherapy (2011)
Get full text
Journal Article
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV‐infected patients
Giacomelli, A, Franzetti, M, Vergani, B, Oreni, L, Morosi, M, Di Cristo, V, Colella, E, Vigano, O, Galli, M, Rusconi, S
Published in Journal of the International AIDS Society (01.11.2012)
Published in Journal of the International AIDS Society (01.11.2012)
Get full text
Journal Article
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
Bulgheroni, Elisabetta, Citterio, Paola, Croce, Francesco, Lo Cicero, Mirko, Viganò, Ottavia, Soster, Francesca, Chou, Ting-Chao, Galli, Massimo, Rusconi, Stefano
Published in Journal of antimicrobial chemotherapy (01.03.2004)
Published in Journal of antimicrobial chemotherapy (01.03.2004)
Get full text
Journal Article
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir
Vergani, Barbara, Cicero, Mirko Lo, Vigano’, Ottavia, Sirianni, Francesca, Ferramosca, Stefania, Vitiello, Paola, Di Vincenzo, Paola, Pasquale, Maria Pia De, Galli, Massimo, Rusconi, Stefano
Published in Journal of clinical virology (01.02.2008)
Published in Journal of clinical virology (01.02.2008)
Get full text
Journal Article
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral-experienced HIV-1-infected subjects treated with tenofovir combination therapy
Lo Cicero, Mirko, Bulgheroni, Elisabetta, Soster, Francesca, Viganò, Ottavia, Cicconi, Paola, Galli, Massimo, Rusconi, Stefano
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.2005)
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.2005)
Get more information
Journal Article
Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility
Bulgheroni, Elisabetta, Croce, Francesco, Citterio, Paola, Viganò, Ottavia, Visonà, Raffaella, Sala, Eugenio, Galli, Massimo, Rusconi, Stefano
Published in Journal of clinical virology (2004)
Published in Journal of clinical virology (2004)
Get full text
Journal Article
Is HAART based on newest active antiretroviral drugs influenced by GSS?
Ortu, MO, Vitiello, PV, Adorni, FA, Rossotti, RR, Di Vincenzo, PDV, Viganò, OV, Galli, M, Rusconi, SR
Published in Journal of the International AIDS Society (10.11.2008)
Published in Journal of the International AIDS Society (10.11.2008)
Get full text
Journal Article